THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Gladius Capital Management LP's Holding History (CIK: 0001540656)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023

Shares 3,190 Value ($000) $35 Avg Close $10.57 Range $9.25 - $11.52

Q4 2022

Shares 3,553 Value ($000) $40 Avg Close $10.51 Range $9.56 - $11.83

Period	Shares	Value ($000)	Average Close	Price Range
Q1 2023	3,190	$35	$10.57	$9.25 - $11.52
Q4 2022	3,553	$40	$10.51	$9.56 - $11.83